Early Stage Scale The company has completed initial analytical electrokinetic protocol development and is preparing to embark on scale-up, indicating a readiness to discuss scalable laboratory workflows and potential equipment or services partnerships.

Niche Biotech Focus Operations centered on high voltage electrokinetic separation and enhanced antibody avidity procedures suggest opportunities for collaborations in analytical separations, protein characterization, or antibody optimization services and instrumentation.

Emerging Revenue Reported revenue in the modest seven-figure range with a very small team signals potential demand for outsourced bioanalytical services, pilot collaborations, or contract research arrangements.

Digital Footprint Presence with diverse tech stack including Squarespace and marketing tools implies openness to digital engagement, online partnerships, and scalable e-commerce or SaaS solutions for research workflows.

Strategic Fit Location in New Jersey biotech corridor and early-stage project phase align with regional funding opportunities, academic collaborations, and industry partnerships that can accelerate scale-up, validation studies, and pilot production.